⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Mahindra Manulife Value Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Mahindra Manulife MF | HDFC MF |
| Category | Equity - Value Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹11.85 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | NIFTY 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Krishna Sanghavi | Nikhil Mathur |
| Inception | 03 Mar 2025 | 04 Oct 2023 |
| Returns | ||
| 1Y | 0.01% | 22.64% |
| 3Y | — | 30.41% |
| 5Y | — | — |
| Since Inception | 11.57% | 29.15% |
| Risk | ||
| 13.08 | 14.07 | |
| 0.96 | 0.59 | |
| 0.52 | 1.59 | |
| 6.65 | 21.67 | |
| 0.95 | 3.48 | |
| -9.90% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.06% | 1.03% |
| Exit Load | 0.50% on or before 3M, Nil after 3M | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹500 | ₹100 |
| Min Lumpsum | ₹1,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Mahindra Manu…98%
HDFC MF98%
1.6%Only 1.6% of holdings by weight are common between Mahindra Manulife MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingMahindra Manulife MFHDFC MF
Glenmark Pharmaceuticals Ltd.1.65%2.09%
Category context: Equity vs Equity. Open the full Screener →